Progesterone-induced blocking factor and cytokine profile in women with threatened pre-term delivery

American Journal of Reproductive Immunology

Volumn 61, Issue 5, 2009, Pages 330-337

  Hudić, Igor ^a   Fatušić, Zlatan ^a   Szekeres bartho, Julia ^b   Balić, Devleta ^a   Polgar, Beáta ^b   Ljuca, Dženita ^a   Dizdarević Hudić, Larisa ^c  

^a UNIVERSITY CLINICAL CENTER TUZLA   (Bosnia and Herzegovina)

^b UNIVERSITY OF PÉCS   (Hungary)

^c UNIVERSITY CLINICAL CENTRE TUZLA   (Bosnia and Herzegovina)

Author keywords

Anti inflammatory cytokines; Pre term delivery; Pro inflammatory cytokines; Progesterone induced blocking factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; PROGESTERONE INDUCED BLOCKING FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATION PERIOD; HUMAN; NEWBORN; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ADULT; CYTOKINES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-6; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY PROTEINS; PROSPECTIVE STUDIES; SUPPRESSOR FACTORS, IMMUNOLOGIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64249161606     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2009.00699.x     Document Type: Article

References (38)

1. Balić D, Latifagić A, Hudić I: Insulin-like growth factor-binding protein 1(IGFBP-1) in cervical secretions as a predictor of pretem delivery. J Maternal-Fetal Neonatal Med 2008; 21:297-300.
2. Savitz DA, Blackmore CA, Thorp JM: Epidemiologic characteristics of preterm delivery: Etiologic heterogeneity. Am J Obstet Gynecol 1991; 164:467-771.
3. Stites DP, Bugbee S, Siiteri PK: Differential actions of progesterone and cortisol on lymphocyte and monocyte interaction during lymphocyte activation - relevance to immunosuppression in pregnancy. J Reprod Immunol 1983; 5:215-228.
4. Kalinka J, Szekeres-Bartho J: The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion. Am J Reprod Immunol 2005; 53:166-171.
5. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Totok A, Pacsa AS: The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxiciti: 1. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostanglandin synthesis. Am J Reprod Immunol Microbiol 1985; 9:15-18.
6. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G: Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 1989; 122:281-294.
7. Szekeres-Bartho J, Par G, Dombay Gy, Smart YC, Volgyi Z: The anti-abortive effect of progesterone-induced blocking factor in mice is manifested by modulating NK activity. Cell Immunol 1997; 177:194-199.
8. Szekeres-Bartho J, Par G, Szereday L, Smart CY, Achacz I: Progesterone and non-specific immunological mechanisms in pregnancy. Am J Reprod Immunol 1997; 38:176-182.
9. Szekeres-Bartho J, Szekeres GY, Debre P, Autran B, Chaouat G: Reactivity of lymphocytes to a progesterone receptor-specific monoclonal antibody. Cell Immunol 1990; 125:273-283.
10. Szereday L, Varga P, Szekeres-Bartho J: Cytokine production by lymphocytes in pregnancy. Am J Reprod Immunol 1997; 38:418-422.
11. Szekeres-Bartho J, Wegmann TG: A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996; 2:81-95.
12. Polgar B, Nagy E, Miko E, Varga P, Szekeres-Bartho J: Urinary progesterone-induced blocking factor concentration is related to pregnancy outcome. Biol Reprod 2004; 71:1699-1705.
13. Mackenzie R, Walker M, Armson A, Hannah ME: Progesterone for the prevention of preterm birth among women at increased risk: A systematic review and meta-analysis of randomized controlled trials. Am J Obstet Gynecol 2006; 194:1234-1242.
14. Raghupathy R, Kalinka J: Cytokine imbalance in pregnancy complications and its modulation. Front Biosci 2008; 13:985-994.
15. Elovitz MA, Mrinalini C: The use of progestational agents for preterm birth: Lessons from a mouse model. Am J Obstet Gynecol 2006; 195:1004-1010.
16. Mercer B, Goldenberg R, Das A, Moawad AH, Iams JD, Meis PJ, Copper RL, Johnson F, Thom E, McNellis D, Miodovnik M, Menard MK, Caritis SN, Thurnau GR, Bottoms SF, Aoberts J: The preterm prediction study: a clinical risk assessment system. Am J Obstet Gynecol 1996; 174:1885-1893.
17. Sfakianaki AK, Norwitz ER: Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med 2006; 19:763-772.
18. Wegmann TG, Lin H, Guilbert L, Mossmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14:353-356.
19. Hanna N, Bonifacio L, Weinberger B, Reddy P, Murphy S, Romero R, Sharma S: Evidence for IL-10 mediated inhibition of cyclooxygenase-2 (COX-2) expression and prostaglandin production by preterm human placenta. Am J Reprod Immunol 2006; 55:19-27.
20. Mitchell MD, Trautman MS, Dudley DJ: Cytokine networking in the placenta. Placenta 1993; 14:249-275.
21. Romero R, Avila C, Santhanam U, Sehgal PB: Amniotic fluid interleukin-6 in preterm labor. Association with infection. J Clin Invest 1990; 85:1392-1400.
22. Shields AD, Wright J, Paonessa DJ, Gotkin J, Howard BC, Hoeldtke NJ, Napolitano PG: Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model. Am J Obstet Gynecol 2005; 193(3 pt 2):1144-1148.
23. Turhan NO, Karabulut A, Adam B: Maternal serum IL-6 levels in preterm labor: Prediction of admission-to-delivery interval. J Perinatal Med 2000; 28:133-139.
24. Murtha AP, Greig PC, Jimmerson CE, Herbert WN: Maternal serum IL-6 concentration as a marker for impending preterm delivery. Obstet Gynecol 1998; 91:161-164.
25. Wilke C, Renz H, Tekesin I, Hellmeyer L, Herz U, Schmidt S: Suppression of IL-2 and INF-gamma production in women with spontaneous preterm labor. J Perinat Med 2006; 34:20-27.
26. El-Shazly S, Makhseed M, Azizieh F, Raghupathy R: Increased expression of proinflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. Am J Reprod Immunol 2004; 52:45-52.
27. Makhseed M, Raghupathy R, El-Shazly S, Azizieh F, Al-Harmi JA, Al-Azemi MM: Pro-inflammatory maternal cytokine profile in preterm delivery. Am J Reprod Immunol 2003; 49:308-318.
28. Curry AE, Vogel I, Drews C, Schendel D, Skogstrand K, Flanders WD, Hougaard D, Olsen J, Thorsen P: Mid-pregnancy maternal plasma levels of interleukin 2, 6, 12, TNF-alfa, INF-gamma and granulocyte colony-stimulating factor and spontaneous preterm delivery. Acta Obstet Gynecol Scand 2007; 86:1103-1110.
29. Raghupathy R, Al Mutawa E, Makhseed M, Al-Azemi M, Azizieh F: Redirection of cytokine production by lymphocytes from women with preterm delivery by dydrogesterone. Am J Reprod Immunol 2007; 58:31-38.
30. von Minckwitz G, Grischke E, Schwab S, Hettinger S, Loibl S, Aulmann M, Kaufmann M: Predictive value of serum IL-6 and IL-8 levels in preterm labor or rupture of the membranes. Acta Obstet Gynecol Scand 2000; 79:667-672.
31. Maymon E, Ghezzi F, Edwin SS, Mazor M, Yoon BH, Gomez R, Romero R: The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 1999; 181(5 pt 1):1142-1148.
32. El-Harith el-HA: The cytokine TNF-alpha. Genetics and suitability for prenatal risks assessment. Saudi Med J 2004; 25:135-140.
33. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 1993; 11:165-190.
34. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-1220.
35. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ: Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184:539-548.
36. Bennett WE, Lagoo-Deenadayalan S, Whitworth NS, Brackin MN, Hale E, Cowan BD: Expression and production of interleukin 10 by human trophoblasts: Relationship to pregnancy immunotolerance. Early Pregnancy 1997; 3:190-198.
37. Hanna N, Hanna I, Hleb M, Wagner E, Dougherty J, Balkundi D, Padbury J, Sharma S: Gestational age-dependent expression of IL-10 and its receptor in human placental tissues and isolated cytotrophoblasts. J Immunol 2000; 164:5721-5728.
38. Mondestin-Sorrentino M, Smulian JC, Vintzileos AM, Sorrentino D, Ananth CV, Sharma S, Hanna NN: Variations in cervical IL-10 and IL-8 concentrations throughout gestation in normal pregnancies. Am J Reprod Immunol 2007; 57:482-487.